Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective.

Literature DB >> 23126319

Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective.

Jodi M Lestner¹, P Brian Smith, Michael Cohen-Wolkowiez, Daniel K Benjamin, William W Hope.

Abstract

Invasive fungal infections, although relatively rare, are life-threatening diseases in premature infants and immunocompromised children. While many advances have been made in antifungal therapeutics in the last two decades, knowledge of the pharmacokinetics and pharmacodynamics of antifungal agents for infants and children remains incomplete. This review summarizes the pharmacology and clinical utility of currently available antifungal agents and discusses the opportunities and challenges for future research.

Entities: Disease Species

Mesh：

Substances：
Antifungal Agents

Year: 2013 PMID： 23126319 PMCID： PMC3690098 DOI： 10.1111/bcp.12025

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

119 in total

1. Voriconazole in newborns.

Authors: Vikas Kohli; Vikas Taneja; Poonam Sachdev; Raja Joshi
Journal: Indian Pediatr Date: 2008-03 Impact factor: 1.411

2. Renal candidiasis in neonates with candiduria.

Authors: K Bryant; C Maxfield; G Rabalais
Journal: Pediatr Infect Dis J Date: 1999-11 Impact factor: 2.129

3. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.

Authors: Flavio Queiroz-Telles; Eitan Berezin; Guy Leverger; Antonio Freire; Annalie van der Vyver; Tawee Chotpitayasunondh; Josip Konja; Heike Diekmann-Berndt; Sonja Koblinger; Andreas H Groll; Antonio Arrieta
Journal: Pediatr Infect Dis J Date: 2008-09 Impact factor: 2.129

4. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

Authors: Peter G Pappas; Coleman M F Rotstein; Robert F Betts; Marcio Nucci; Deepak Talwar; Jan J De Waele; Jose A Vazquez; Bertrand F Dupont; David L Horn; Luis Ostrosky-Zeichner; Annette C Reboli; Byungse Suh; Raghunadharao Digumarti; Chunzhang Wu; Laura L Kovanda; Leah J Arnold; Donald N Buell
Journal: Clin Infect Dis Date: 2007-08-29 Impact factor: 9.079

5. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.

Authors: William W Hope; Diana Mickiene; Vidmantas Petraitis; Ruta Petraitiene; Amy M Kelaher; Joanna E Hughes; Margaret P Cotton; John Bacher; James J Keirns; Donald Buell; Gloria Heresi; Daniel K Benjamin; Andreas H Groll; George L Drusano; Thomas J Walsh
Journal: J Infect Dis Date: 2008-01-01 Impact factor: 5.226

6. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors: Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal: Clin Infect Dis Date: 2008-01-15 Impact factor: 9.079

7. Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.

Authors: Susan M Abdel-Rahman; Richard F Jacobs; Joseph Massarella; Ralph E Kauffman; John S Bradley; Hui C Kimko; Gregory L Kearns; Kevin Shalayda; Christopher Curtin; Samuel D Maldonado; Jeffrey L Blumer
Journal: Antimicrob Agents Chemother Date: 2007-05-21 Impact factor: 5.191

Review 8. Posaconazole for paediatric patients: status of development and future perspectives.

Authors: Andreas H Groll; Thomas Lehrnbecher
Journal: Mycoses Date: 2008-09 Impact factor: 4.377

9. Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing.

Authors: William W Hope; Nita L Seibel; Cindy L Schwartz; Antonio Arrieta; Patricia Flynn; Aziza Shad; Edythe Albano; James J Keirns; Donald N Buell; Tawanda Gumbo; George L Drusano; Thomas J Walsh
Journal: Antimicrob Agents Chemother Date: 2007-07-16 Impact factor: 5.191

10. A comparison of AmBisome to amphotericin B for treatment of systemic candidiasis in very low birth weight infants.

Authors: Ga Won Jeon; Soo Hyun Koo; Jang Hoon Lee; Jong Hee Hwang; Sung Shin Kim; Eun Kyung Lee; Wook Chang; Yun Sil Chang; Won Soon Park
Journal: Yonsei Med J Date: 2007-08-31 Impact factor: 2.759

9 in total

Review 1. Invasive fungal infections in neonates: a review.

Authors: Kristin E D Weimer; P Brian Smith; Mihai Puia-Dumitrescu; Samia Aleem
Journal: Pediatr Res Date: 2021-12-09 Impact factor: 3.756

Review 2. Advances in the treatment of invasive neonatal candidiasis.

Authors: Lorena Botero-Calderon; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal: Expert Opin Pharmacother Date: 2015-04-05 Impact factor: 4.103

3. Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance.

Authors: Nicola Farrington; Laura McEntee; Adam Johnson; Jennifer Unsworth; Christopher Darlow; Ana Jimenez-Valverde; Christoph Hornik; Rachel Greenberg; Julie Schwartz; Shampa Das; William Hope
Journal: Antimicrob Agents Chemother Date: 2022-03-22 Impact factor: 5.938

Review 4. Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients.

Authors: Kevin J Downes; Brian T Fisher; Nicole R Zane
Journal: Paediatr Drugs Date: 2020-04 Impact factor: 3.022

5. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors: Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal: Clin Infect Dis Date: 2015-12-16 Impact factor: 9.079